Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial-Reference-Cited by-同舟云学术

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

Published:2010-07 Issue:9737 Volume:376 Page:245-251
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Audeh M William,Carmichael James,Penson Richard T,Friedlander Michael,Powell Bethan,Bell-McGuinn Katherine M,Scott Clare,Weitzel Jeffrey N,Oaknin Ana,Loman Niklas,Lu Karen,Schmutzler Rita K,Matulonis Ursula,Wickens Mark,Tutt Andrew

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. The PARP superfamily;Amé;BioEssays,2004

2. The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability;Gudmundsdottir;Oncogene,2006

3. Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences;Tutt;EMBO J,2001

4. Brca1 controls homology-directed DNA repair;Moynahan;Mol Cell,1999

5. BRCA2 is required for homology-directed repair of chromosomal breaks;Moynahan;Mol Cell,2001

Cited by 1231 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted gene panel sequencing of liquid and tissue biopsies reveals actionable genomic alterations in Ghanaian metastatic breast cancer cases;Translational Oncology;2024-11

2. The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research;Molecular Cancer;2024-08-14

3. Mechanism and rational combinations with GP‐2250, a novel oxathiazine derivative, in ovarian cancer;Cancer Medicine;2024-08

4. Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer;Frontiers in Oncology;2024-07-29

5. Olaparib enhancing radiosensitization and anti-metastatic effect of oral cancer by targeting IL-17A signal;2024-06-18